Pharma minutes

Tuesday 16 January 2018

Labels: Job

FDA approves drug to treat Duchenne muscular dystrophy

The U.S. Food and Drug Administration today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and o...
Trump Volatility Index Takes Pharma Companies on a Wild Ride

Few industries are getting the Trump Treatment quite like Big Pharma. Drug stocks initially jumped after Donald Trump was elected, on ...
Big Pharma’s Offer to Trump: Discounts When Drugs Don’t Work- Must read

President Donald Trump says drug prices are astronomical and something needs to be done. Pharmaceutical giants have an answer that doesn’t...
Granules to invest $20 mn in US subsidiary Granules Pharmaceulticals Inc, Q3 net up 34% at Rs. 39 cr

Granules India Ltd has announced its move to invest $20 million in its wholly-owned subsidiary Granules Pharmaceulticals Inc. The comp...
FDA Inspection: Dishman Pharma gets USFDA report on closure of inspection of its Gujarat facility

Drug firm Dishman Pharmaceuticals and Chemicals Ltd has received an Establishment Inspection Report (EIR) from the US health regulator o...

Simple theme. Powered by Blogger.